Philip J. Saylor

Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Timothy D. Gilligan, Daniel W. Lin, Rahul Aggarwal et al. · Journal of the National Comprehensive Cancer Network · 2019 · 451 citations

Medicine, Oncology, Surgery +16

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience

Nicholas J. Giacalone, William U. Shipley, R.H. Clayman et al. · European Urology · 2017 · 400 citations

Medicine, Surgery, Urology +14

Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment

Youmna Kfoury, Ninib Baryawno, Nicolas Sévère et al. · Cancer Cell · 2021 · 275 citations · Full text

Medicine, Immunology, Oncology +17

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Matthew R. Smith, Susan Halabi, Charles J. Ryan et al. · Journal of Clinical Oncology · 2014 · 250 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses

Taghreed Hirz, Shenglin Mei, Hirak Sarkar et al. · Nature Communications · 2023 · 247 citations · Full text

Life Sciences, Immunology, Oncology +17